Section 410 IAC 29-1-21 - "Retesting" definedAuthority: IC 16-41-39.4-1
Affected: IC 16-41-39.4
Sec. 21.
"Retesting" means additional testing to monitor a child's blood lead level over time in accordance with the following schedule, unless a primary care physician or local health department determines retesting should occur within shorter intervals:
(1) Within twelve (12) months for results between zero (0) and three and four-tenths (3.4) µ/dL.(2) Within three (3) to six (6) months for results between three and five-tenths (3.5) and nine and nine-tenths (9.9) µ/dL.(3) Within one (1) to three (3) months for results between ten (10) and nineteen and nine-tenths (19.9) µ/dL.(4) Within two (2) weeks to one (1) month for results between twenty (20) and forty-four and nine-tenths (44.9) µ/dL.(5) By the venous method within one (1) month after completion of chelation therapy for results greater than forty-five (45) µ/dL.Indiana State Department of Health; 410 IAC 29-1-21; filed Jan 2, 2007, 2:49 p.m.: 20070131-IR-410050189FRA; filed Apr 20, 2009, 3:12 p.m.: 20090520-IR-410080318FRA; readopted filed Sep 11, 2013, 3:19 p.m.: 20131009-IR-410130346RFAReadopted filed 11/13/2019, 3:14 p.m.: 20191211-IR-410190391RFAFiled 9/1/2022, 4:06 p.m.: 20220928-IR-410220119FRA